Valuation: Synovics Pharmaceuticals, Inc.

Market Cap 1.64M 1.41M 1.32M 1.2M 2.27M 156M 2.29M 15.54M 6.05M 78.91M 6.16M 6.03M 261M P/E 2007
-0.73x
P/E 2008 -2.06x
Enterprise Value 8.13M 6.97M 6.53M 5.96M 11.25M 775M 11.36M 76.99M 29.97M 391M 30.52M 29.86M 1.29B EV / Sales 2007
1.81x
EV / Sales 2008 0.6x
Free-Float
95.75%
Yield 2007 *
-
Yield 2008 -
Change 5-day change 1-year change 3-year change Capi.($)
-99.50%-.--% - - 3.65K
-3.85%-4.56%+66.03%+120.61% 1,100B
-0.78%-0.23%+54.56%+66.04% 658B
-1.50%-0.56%+26.93%+79.39% 470B
-1.43%+0.57%+42.55%+42.58% 372B
-0.89%+0.53%+26.18%+41.28% 304B
-1.73%+2.37%+3.91%+14.18% 264B
-0.60%-0.22%+52.42%+72.05% 239B
-0.60%+2.89%-12.21%-52.34% 213B
-0.35%+0.61%+29.41%+92.76% 184B
Average -11.17%+3.01%+32.20%+52.95% 422.54B
Weighted average by Cap. -1.90%+2.21%+42.42%+70.66%

Financials

2007 2008
Net sales 23.47M 20.11M 18.84M 17.21M 32.48M 2.24B 32.8M 222M 86.52M 1.13B 88.11M 86.19M 3.74B 25.96M 22.24M 20.84M 19.04M 35.93M 2.47B 36.29M 246M 95.71M 1.25B 97.47M 95.35M 4.13B
Net income -20.86M -17.87M -16.75M -15.3M -28.87M -1.99B -29.16M -198M -76.9M -1B -78.32M -76.61M -3.32B -4.01M -3.43M -3.22M -2.94M -5.54M -382M -5.6M -37.94M -14.77M -193M -15.04M -14.71M -638M
Net Debt 18.79M 16.1M 15.09M 13.78M 26.01M 1.79B 26.26M 178M 69.28M 904M 70.55M 69.02M 2.99B 6.49M 5.56M 5.21M 4.76M 8.98M 619M 9.07M 61.45M 23.92M 312M 24.36M 23.83M 1.03B
Logo Synovics Pharmaceuticals, Inc.
Synovics Pharmaceuticals, Inc. (Synovics) is a specialty pharmaceutical company engaged in the development, manufacturing and commercialization of generic over the counter (OTC) pharmaceutical products and generic prescription drug products. The Company is a manufacturer, packager and distributor of private label, or store brand, OTC products to chain drug stores, wholesalers and distributors throughout the United States. The Company’s OTC product categories include analgesics, cough and cold, antihistamines, asthma relief and laxatives. The Company has two primary subsidiaries, Kirk Pharmaceuticals, LLC (Kirk), and ANDAPharm, LLC (ANDAPharm). Kirk manufactures and distributes OTC products developed by or licensed to the Company. ANDAPharm serves as the product research and RX manufacturing arm of the Company with a focus on the development of active compounds for drugs.
Employees
-